Understanding the $200 Million FDA Approval Loophole
Mar 17th, 2010 | By Patrick Cox | Category: Featured, Penny stocks, Technology
One key loophole in the FDA approval process could leave the door open for small drug developers to walk away with hundreds of millions of dollars. But not all drug companies get an equal shot at this huge advantage. Here’s a glimpse at how it breaks down – and how ...read more
